Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non …
M Back, T Eade - 2016 - centralcoast.intersearch.com.au
BACKGROUND: Currently there are very few biomarkers to identify head and neck
squamous cell carcinoma (HNSCC) cancer patients at a greater risk of recurrence and …
squamous cell carcinoma (HNSCC) cancer patients at a greater risk of recurrence and …
[PDF][PDF] Immunomodulation within the Head and Neck Tumour Microenvironment
PF Murray - 2014 - hull-repository.worktribe.com
Abstract Changes in the immune response have been implicated in the progression of
squamous cell carcinoma of the head and neck (HNSCC). Evidence is emerging that …
squamous cell carcinoma of the head and neck (HNSCC). Evidence is emerging that …
Tamponamento do cálcio nuclear como adjuvante no tratamento de tumores de cabeça & pescoço resistentes à radioterapia
LM Andrade - 2014 - arca.fiocruz.br
A radioterapia é uma modalidade importante para tratar o câncer de Cabeça e Pescoço, no
entanto falhas do tratamento já foram observadas e recorrência da doença é comum. Novas …
entanto falhas do tratamento já foram observadas e recorrência da doença é comum. Novas …
Dendritic cell vaccines targeting survivin in head and neck cancer
WT Lee - Immunotherapy, 2013 - Taylor & Francis
Evaluation of: Turksma AW, Bontkes HJ, Ruizendaal JJ et al. Exploring dendritic cell based
vaccines targeting survivin for the treatment of head and neck cancer patients. J. Transl …
vaccines targeting survivin for the treatment of head and neck cancer patients. J. Transl …
[引用][C] Defining the Molecular Profile of Oral Tongue Squamous Cell Carcinomas and Its Impact on Patient Outcome
AML Lim - 2014 - University of Melbourne, Department …